Insulin dysregulation (ID), characterized by hyperinsulinemia and an excessive response to an oral or intravenous glucose challenge, is a core component of the pathophysiology of equine metabolic syndrome (EMS) (1–3). This evidence concerns the gene INS and hyperinsulinism.